MEI Pharma, Inc.

NasdaqCM:MEIP 株式レポート

時価総額:US$18.7m

MEI Pharma マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Jay File

最高経営責任者

US$655.7k

報酬総額

CEO給与比率68.6%
CEO在任期間1.3yrs
CEOの所有権n/a
経営陣の平均在職期間2.1yrs
取締役会の平均在任期間3.9yrs

経営陣の近況

Recent updates

New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Feb 17
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)

Dec 30
Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)

Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)

Nov 19
Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)

We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely

May 18
We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely

Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022

Mar 26
Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022

Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts

Feb 12
Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts

MEI Pharma: Another PI3K Delta Progressing To The FDA

Feb 01

Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates

Dec 02
Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates

We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate

Nov 04
We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate

MEI Pharma EPS misses by $0.12, misses on revenue

May 06

MEI Pharma promotes Richard Ghalie to chief medical officer

Apr 30

MEI Pharma shares rise 4% as Wells Fargo says voruciclib undervalued

Apr 26

The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding

Feb 25
The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding

New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Feb 11
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

CEO報酬分析

MEI Pharma の収益と比較して、Jay File の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$47m

Jun 30 2024US$656kUS$450k

US$18m

報酬と市場: Jayの 総報酬 ($USD 655.65K ) は、 US市場 ($USD 650.80K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Jayの報酬と会社の業績を比較するにはデータが不十分です。


CEO(最高経営責任者

Jay File (54 yo)

1.3yrs

在職期間

US$655,650

報酬

Mr. Justin J. File, also known as Jay, serves as CFO & Corporate Secretary at MEI Pharma, Inc. since August 01, 2023 and serves as its Acting Chief Executive Officer from August 01, 2024. He had been an Ex...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Justin File
Acting CEO1.3yrsUS$655.65kデータなし
Yomara Gomez-Naiden
Senior Vice President of Operations & Quality1.3yrsデータなしデータなし
Nicole Iida
Vice President of Legal Affairs1.8yrsデータなしデータなし
Anne Frese
Chief People Officer2.4yrsデータなしデータなし
Robert Mass
Strategic Advisor13.4yrsUS$755.98kデータなし
David Walsey
Senior Vice President of Corporate Affairs3.5yrsデータなしデータなし

2.1yrs

平均在職期間

経験豊富な経営陣: MEIPの経営陣は 経験豊富 であると考えられます ( 2.1年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Frederick Driscoll
Independent Chairperson6.8yrsUS$117.20k0.028%
$ 5.3k
Nicholas Glover
Independent Non-Executive Director11.4yrsUS$122.78k0%
$ 0
Thomas Reynolds
Independent Non-Executive Director11.8yrsUS$115.28k0.0075%
$ 1.4k
Steven Wood
Independent Non-Executive Director1.1yrsUS$112.40k0.14%
$ 26.3k
James Flynn
Independent Directorless than a yearUS$114.07k0.12%
$ 22.2k
Taheer Datoo
Directorless than a yearUS$68.06kデータなし

3.9yrs

平均在職期間

49yo

平均年齢

経験豊富なボード: MEIPの 取締役会経験豊富 であると考えられます ( 3.9年の平均在任期間)。